𝔖 Bobbio Scriptorium
✦   LIBER   ✦

903 The Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) Trial

✍ Scribed by S.G. Goodman; M.T. Roe; P.W. Armstrong; H.D. White; K.A. Fox; D. Prabhakaran; E. Brown; Y. Lokhnygina; E. Ohman

Book ID
116364346
Publisher
Pulsus Group Inc
Year
2012
Tongue
English
Weight
144 KB
Volume
28
Category
Article
ISSN
0828-282X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Study design and rationale of a comparis
Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non–ST-segment elevation myocardial infarction: The TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial
✍ Chee Tang Chin; Matthew T. Roe; Keith A.A. Fox; Dorairaj Prabhakaran; Debra A. M πŸ“‚ Article πŸ“… 2010 πŸ› Elsevier Science 🌐 English βš– 311 KB
The Efficacy and Safety of Prasugrel Wit
The Efficacy and Safety of Prasugrel With and Without a Glycoprotein IIb/IIIa Inhibitor in Patients With Acute Coronary Syndromes Undergoing Percutaneous Intervention: A TRITON–TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis In Myocardial Infarction 38) Analysis
✍ Michelle O'Donoghue; Elliott M. Antman; Eugene Braunwald; Sabina A. Murphy; P. G πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 480 KB